Evexia Lifecare appoints Sagar Sandeep Pagariya as company secretary

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Evexia Lifecare appointed Sagar Sandeep Pagariya as Company Secretary and Compliance Officer
  • Appointment effective from October 14, 2026
  • Decision taken during board meeting held on October 13, 2026
  • Pagariya is an Associate Company Secretary with ACS number 62781
powered bylight_fuzz_icon
53439757

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare appointed Sagar Sandeep Pagariya as Company Secretary and Compliance Officer effective October 14, 2026. The appointment was approved during the board meeting held on October 13, 2026.

Board meeting details

The Board of Directors convened at the corporate office in Vadodara, Gujarat. The meeting commenced at 4:00 pm and concluded at 4:30 pm. This action was taken pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment specifics

Pagariya holds an Associate Company Secretary (ACS) qualification with membership number 62781. He assumes the role of Key Managerial Personnel (KMP) for the pharmaceutical company. The appointment ensures continued compliance with statutory governance requirements.

Governance update

The company informed BSE Ltd. about the outcome of the board meeting. Jayeshbhai R. Thakkar, Managing Director, signed the disclosure notice digitally on October 13, 2026. No other agenda items were disclosed in the filing.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+1.85%+10.55%+33.33%+272.88%+8.37%-70.94%

Will Evexia Lifecare's recent governance changes coincide with any upcoming strategic expansions or regulatory filings?

How might the new Compliance Officer's tenure influence Evexia Lifecare's adherence to evolving SEBI disclosure norms?

Are there indications that this appointment is part of a broader leadership restructuring within the company's management team?

Evexia Lifecare shareholders approve all AGM resolutions with over 99.9% support

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Shareholders approved all 10 resolutions with over 99.9% votes in favor
  • Material related party transactions with eight entities received 99.93% support
  • Re-appointment of director Hasmukhbhai Thakkar passed with 99.92% votes
  • No votes were cast during the live AGM session; all voting was remote
powered bylight_fuzz_icon
52328018

*this image is generated using AI for illustrative purposes only.

Evexia Lifecare Limited shareholders approved all ten resolutions at the 35th Annual General Meeting held on September 30, 2026, with over 99.9% of valid votes cast in favor.

The meeting, conducted via video conferencing, sought approval for material related party transactions with eight entities and the adoption of audited financial statements for FY26. Jayesh Raichandbhai Thakkar, Managing Director and Chairperson, presided over the session which concluded at 3:15 pm.

Key Agenda Items

The Board placed several items before shareholders for approval through remote e-voting. These included the adoption of standalone and consolidated audited financial statements for FY26 and the re-appointment of Mr. Hasmukhbhai Dhanjibhai Thakkar as a director retiring by rotation.

A significant portion of the agenda focused on approving material related party transactions. The company sought ordinary resolutions to approve dealings with the following entities:

  • Kavir Edible Oil Limited
  • Kavir Cable Private Limited
  • Evexia Lifecare Africa Limited
  • Diponed Research International Private Limited
  • Diponed Bio Private Limited
  • Vittals Medicare Private Limited
  • Evexia PAN Africa Limited
  • Heemsol Energy System Private Limited

Governance and Attendance

The following directors and key managerial personnel were present at the meeting:

Name Designation
Jayesh Raichandbhai Thakkar Executive Director-Chairperson-MD
Krupalibahen Rajeshbhai Mehta Non-Executive Independent Director
Kartik Kumar Bakulchandra Mistry Non-Executive Independent Director
Mohammadraza Makrani Non-Executive Independent Director
Hasmukhbhai Dhanjibhai Thakkar Non-Executive Non-Independent Director
Parth Patel Non-Executive Independent Director
Bhavesh Desai Chief Financial Officer

Brajesh Gupta served as the Secretarial Auditor and Scrutinizer, while Tejas Soni attended as the Statutory Auditor. The Chairman confirmed that the requisite quorum was present to conduct the proceedings.

Voting Results

Shareholders cast votes electronically on all resolutions. No votes were cast during the live AGM session; all voting occurred via remote e-voting prior to the meeting. The scrutinizer's report confirmed that all resolutions passed with a substantial majority.

Resolution Item Votes In Favor (%) Votes Against (%)
Adoption of FY26 Financial Statements 99.97% 0.03%
Re-appointment of Director (Hasmukhbhai Thakkar) 99.92% 0.08%
Related Party Transactions (All 8 Entities) 99.93% 0.07%

The consolidated results were announced following the scrutiny process completed by Brajesh Gupta & Co. The results are displayed at the registered office and disseminated on the company's website and NSDL platform.

Historical Stock Returns for Evexia Lifecar

1 Day5 Days1 Month6 Months1 Year5 Years
+1.85%+10.55%+33.33%+272.88%+8.37%-70.94%

How will the approved material related party transactions with the eight affiliated entities impact Evexia Lifecare's future operational costs and profit margins?

What are the specific strategic objectives behind Evexia Lifecare's continued expansion and dealings with its African subsidiaries, Evexia Lifecare Africa Limited and Evexia PAN Africa Limited?

Given the near-unanimous shareholder approval, how might this governance stability influence institutional investor confidence and the company's stock valuation in the upcoming quarters?

More News on Evexia Lifecar

1 Year Returns:+8.37%